Internal Medicine, Cardiovascular Disease · San Antonio, TX
NPI
1376634311
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
215 E Quincy St Ste 604
San Antonio, TX, 78215
Phone (726) 842-9799
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
316 services
Medicare patients, 2024
93
Average age 76
Drug cost, 2024
$1.1M
1,522 prescriptions
Company payments, 2025
$714
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meenakshi A Bhalla was code 99232 (hospital e&m - subsequent), 93 times for 28 patients. In total Meenakshi A Bhalla billed 316 services in 20 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 93 | 28 | $60.75 | $5,650 |
| 99214 Office E&M - Established | Office | 70 | 24 | $94.34 | $6,604 |
| 93000 Electrocardiogram | Office | 43 | 40 | $10.53 | $453 |
| 99213 Office E&M - Established | Office | 21 | 17 | $53.35 | $1,120 |
| 99222 Hospital E&M - Initial | Facility | 18 | 15 | $102.32 | $1,842 |
By year: 2022 $41K for 489 services; 2023 $20K for 290 services; 2024 $20K for 316 services.
Medicare prescription drug claims, 2024
In 2024, the drug Meenakshi A Bhalla prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 227 prescriptions and refills. In total Meenakshi A Bhalla wrote 1,522 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 227 | 293 | 45 | $192K |
| Metoprolol Succinate Generic | 153 | 295 | 41 | $1,446 |
| Farxiga Dapagliflozin Propanediol | 84 | 136 | 18 | $77K |
| Jardiance Empagliflozin | 79 | 124 | 21 | $71K |
| Spironolactone Generic | 78 | 154 | 31 | $446 |
| Losartan Potassium Generic | 73 | 154 | 20 | $437 |
| Warfarin Sodium Generic | 62 | 144 | 12 | $667 |
| Digoxin Generic | 60 | 110 | 17 | $1,554 |
| Bumetanide Generic | 53 | 99 | 16 | $757 |
| Atorvastatin Calcium Generic | 50 | 126 | 21 | $482 |
| Carvedilol Generic | 42 | 85 | 16 | $307 |
| Clopidogrel Clopidogrel Bisulfate | 41 | 57 | 16 | $181 |
| Isosorbide Dinitrate Generic | 40 | 62 | 12 | $18K |
| Hydralazine Hcl Generic | 40 | 81 | 17 | $394 |
| Eliquis Apixaban | 39 | 65 | 12 | $37K |
Brand drugs: 508 claims; generic drugs: 1,014 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meenakshi A Bhalla $714 ($714 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abiomed with $184.
| Company | Payments | Amount |
|---|---|---|
| Abiomed JNJ | 3 | $184 |
| Abbott Laboratories ABT | 2 | $139 |
| CVRx, Inc. CVRX | 2 | $124 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $55.78 |
| Pfizer Inc. PFE | 2 | $54.87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37.09 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $28.21 |
| LeMaitre Vascular, Inc. LMAT | 1 | $27.27 |
| Scpharmaceuticals Inc. SCPH | 1 | $26.01 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $19.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.